1,764,042 research outputs found
Review of V.S. Naipaul: An Anthology of 21st Century Criticism edited by Ajay K. Chaubey
No full textReview of V.S. Naipaul: An Anthology of 21st Century Criticism edited by Ajay K. Chaube
The Question of Land and Infrastructure Development in India: Urgently Required Reforms for Fairness and Infrastructural Development
Full text linkLand in India is problematic largely because of archaic and perverse provisions in the practice and the law. The new Land Acquisition Amendment Bill does go some way to correct the anti-democratic and imperial provisions of the old 1894 Act. Other regulatory restraints stand in the way of fair compensation to sellers whether the deal is a sale or an acquisition using eminent domain. Urban planning being based on the “Ricardian Model” and on top of asymmetrically applied regulatory constraints further depresses the benefit to land owners. As a result very little land is obtainable without dispute and high risk for infrastructure development. In this paper we provide an analytical critique of the law and restrictions as also of the framework of urban planning and provide a justification for why major change is required in the approach to land markets, land acquisition and urban planning. We also provide the key elements of a reformed approach that can create a win-win framework for development. We also present our suggestions on how the proposed Amendment to the Land Acquisition Act can be changed to make the Act functional and remove the residual perversities therein.
Utilizing biomarkers in colorectal cancer: an interview with Ajay Goel
No full text Ajay Goel speaks to Rachel Jenkins, Commissioning Editor. Ajay Goel, PhD, is a Professor and Director, Center for Gastrointestinal Research, and Director, Center for Translational Genomics and Oncology, at the Baylor Scott & White Research Institute, Baylor University Medical Center in Dallas, Texas. Dr Goel has spent more than 20 years researching cancer and has been the lead author or contributor to over 240 scientific articles published in peer-reviewed international journals and several book chapters. He is also a primary inventor on more than 15 international patents aimed at developing various biomarkers for the diagnosis, prognosis and prediction of gastrointestinal cancers. He is currently using advanced genomic and transcriptomic approaches to develop novel DNA- and miRNA-based biomarkers for the early detection of colorectal cancers. In addition, he is researching the prevention of gastrointestinal cancers using integrative and alternative approaches, including botanical products such as curcumin (from turmeric) and boswellia. Dr Goel is a member of the American Association for Cancer Research (AACR) and the American Gastroenterology Association (AGA) and is on the international editorial boards of several journals including Gastroenterology, Clinical Cancer Research, Carcinogenesis, PLoS ONE, Scientific Reports, Epigenomics, Future Medicine, Alternative Therapies in Heath and Medicine and World Journal of Gastroenterology. He is also actively involved in peer-reviewing activities for more than 100 international scientific journals and various grant review panels of various national and international funding organizations. His research has been actively funded by various private and federal organizations, including funding from the National Cancer Institute (NCI) at the NIH, American Cancer Society (ACS) and other state organizations. He has won more than dozen awards and honors, including the Union of European Gastroenterology Federation's Distinguished Researcher Award, multiple Poster of Distinction Awards from the AGA, and Visiting Professorships from various national and international academic institutions and academic bodies. Some of his key research interests include: Understanding the basic genetics and epigenetic basis of gastrointestinal cancers; Use of epigenetic markers, both DNA and RNA, for the early detection of colorectal, pancreatic and other gastrointestinal cancers; Personalized medicine and treatment of gastrointestinal cancers; Chemoprevention, using complementary and alternative approaches using nutraceuticals such as curcumin, green tea, resveratrol and other botanicals. </jats:p
Remarks by Ajay Banga at the Opening of the 4th International Conference on Financing for Development
No full textIn his speech, World Bank Group President Ajay Banga highlights a critical juncture for global development, marked by persistent challenges and a demographic surge in emerging markets. He emphasizes that unlocking the potential of the next generation requires unprecedented resources and strategic partnerships, especially with the private sector. The World Bank Group is responding with reforms to accelerate impact, streamline operations, and mobilize capital. By focusing on job creation and enabling environments, the Bank aims to address both immediate needs and long-term opportunities. Ultimately, the speech calls for collective action to create the conditions for jobs and unlock a generation’s potential
Remarks by World Bank Group President Ajay Banga at the 2023 Annual Meetings Plenary
Full text linkThis report discusses the remarks
delivered by Ajay Banga, President of the World Bank at the
annual meetings plenary. The World Bank stepped forward to
support the most vulnerable when compounding challenges: the
war in Ukraine, the effects of the pandemic, and
inflation-hit. But the need was so great that we allocated
the majority of our three-year crisis response window in the
first year. Our partnership focuses on three objectives:
attack deforestation in the Amazon, strengthen the
Caribbean’s resilience to natural disasters, and bridge the
digital-access gap across Latin America and the Caribbean
- …
